158 related articles for article (PubMed ID: 20717669)
1. Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer.
Zeimet AG; Reimer D; Schwentner L; Fuchs D; Wolf D; Fuith LC; Fiegl H; Doppler W; Concin N; Daxenbichler G; Marth C
Cancer Immunol Immunother; 2010 Dec; 59(12):1813-23. PubMed ID: 20717669
[TBL] [Abstract][Full Text] [Related]
2. Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO).
Volgger BM; Windbichler GH; Zeimet AG; Graf AH; Bogner G; Angleitner-Boubenizek L; Rohde M; Denison U; Sliutz G; Fuith LC; Fuchs D; Marth C
Ann Oncol; 2016 Sep; 27(9):1740-6. PubMed ID: 27358381
[TBL] [Abstract][Full Text] [Related]
3. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
[TBL] [Abstract][Full Text] [Related]
4. [Activation of the immune system in colorectal carcinoma and its assessment].
Jandík P; Melichar B; Mergancová J; Solichová D; Bures J; Voboril Z; Lukes J
Acta Medica (Hradec Kralove) Suppl; 1997; 40(2):81-2. PubMed ID: 10103145
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of nuclear roundness and neopterin in ovarian cancer.
Marth C; Weger A; Müller-Holzner E; Zeimet AG; Moncayo-Naveda H; Daxenbichler G; Reibnegger G; Fuchs D; Wachter H; Dapunt O
Eur J Cancer; 1993; 29A(13):1863-8. PubMed ID: 8260243
[TBL] [Abstract][Full Text] [Related]
6. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies.
Melichar B; Solichová D; Freedman RS
Int J Gynecol Cancer; 2006; 16(1):240-52. PubMed ID: 16445639
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.
Zeimet AG; Reimer D; Wolf D; Fiegl H; Concin N; Wiedemair A; Wolf AM; Rumpold H; Müller-Holzner E; Marth C
Int J Cancer; 2009 May; 124(10):2353-60. PubMed ID: 19170204
[TBL] [Abstract][Full Text] [Related]
8. Urinary neopterin in patients with liver tumors.
Melichar B; Solichová D; Svobodová I; Urbánek L; Veselý P; Melicharová K
Tumori; 2006; 92(4):318-22. PubMed ID: 17036523
[TBL] [Abstract][Full Text] [Related]
9. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
[TBL] [Abstract][Full Text] [Related]
10. Neopterin: a prognostic variable in operations for lung cancer.
Prommegger R; Widner B; Murr C; Unger A; Fuchs D; Salzer GM
Ann Thorac Surg; 2000 Dec; 70(6):1861-4. PubMed ID: 11156084
[TBL] [Abstract][Full Text] [Related]
11. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
[TBL] [Abstract][Full Text] [Related]
12. Differences in pteridine urinary levels in patients with malignant and benign ovarian tumors in comparison with healthy individuals.
Zvarik M; Martinicky D; Hunakova L; Sikurova L
J Photochem Photobiol B; 2015 Dec; 153():191-7. PubMed ID: 26414289
[TBL] [Abstract][Full Text] [Related]
13. Urinary neopterin in patients with advanced colorectal carcinoma.
Melichar B; Solichová D; Melicharová K; Malírová E; Cermanová M; Zadák Z
Int J Biol Markers; 2006; 21(3):190-8. PubMed ID: 17013802
[TBL] [Abstract][Full Text] [Related]
14. Neopterin in renal cell carcinoma: inhalational administration of interleukin-2 is not accompanied by a rise of urinary neopterin.
Melichar B; Solichová D; Svobodová I; Melicharová K
Luminescence; 2005; 20(4-5):311-4. PubMed ID: 16134219
[TBL] [Abstract][Full Text] [Related]
15. Neopterin is an independent prognostic variable in females with breast cancer.
Murr C; Bergant A; Widschwendter M; Heim K; Schröcksnadel H; Fuchs D
Clin Chem; 1999 Nov; 45(11):1998-2004. PubMed ID: 10545071
[TBL] [Abstract][Full Text] [Related]
16. Preactivated T cells in cancer patients with poor prognosis.
Fuchs DN; Fuith LC; Hausen A; Hetzel H; Reibnegger GJ; Werner ER; Wachter H
Cancer Detect Prev; 1988; 12(1-6):97-103. PubMed ID: 3141055
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
[TBL] [Abstract][Full Text] [Related]
18. Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis.
Giovannoni G; Lai M; Kidd D; Thorpe JW; Miller DH; Thompson AJ; Keir G; Feldmann M; Thompson EJ
Brain; 1997 Jan; 120 ( Pt 1)():1-13. PubMed ID: 9055793
[TBL] [Abstract][Full Text] [Related]
19. A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin.
Isci Bostanci E; Ugras Dikmen A; Girgin G; Gungor T; Baydar T; Nuri Danisman A
Int J Gynecol Cancer; 2017 May; 27(4):754-758. PubMed ID: 28383326
[TBL] [Abstract][Full Text] [Related]
20. Vitamin A status does not influence neopterin production during illness or health in South African children.
Filteau SM; Raynes JG; Simmank K; Wagstaff LA
Br J Nutr; 1998 Jul; 80(1):75-9. PubMed ID: 9797646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
